Abstract: A trophy assembly having a base with an integral lower clip, a column with interior column ribs, in which the lower clip is adapted to engage the column ribs, thereby joining the base and the column when the column is placed over the clip and rotated. A trophy assembly having a base attached to a lid with an integral clip, and a column with interior column ribs, wherein the clip is adapted to engage the column ribs, thereby joining the base, the lid and the column when the column is placed over the clip and rotated. A trophy column having an exterior column surface and an interior column surface with a plurality of inwardly and longitudinally extending ribs. A plastic base for use in a trophy assembly having a base and a column, wherein the base has in integral clip adapted to engage ribs on the interior surface of the column. A figure for use in a trophy assemble having a column with ribs on the interior column surface wherein the figure has an integral clip adapted to engage the ribs.

Abstract: A trophy assembly including a base, lower clip, and column having inwardly extending ribs adapted to engage the lower clip, wherein the base and column are joined when the column is placed over the lower clip and rotated. A method for assembling trophies including selecting a base, column with internal ribs, and a clip, attaching the clip to the base, forming slots in interior ribs of the column, placing the column over the clip and rotating it, whereby the base and column are joined. A trophy assembly further including upper clips adapted to engage inwardly extending column ribs and attached to upper members, wherein the base, column, and upper member are joined when the column is rotated.

Abstract: A doll includes a torso having an opening. A simulated bowel movement may be moved through the opening between positions respectively inside and outside the torso.

Abstract: The effectiveness of interferon for treatment against cancer may be increased by first administering an agent for inhibiting tyrosinase. In this manner the tyrosinase which is known to be produced by malignancies, and which may cause inactivation of the interferon, will be substantially inactivated prior to the interferon administration.

Abstract: Mandelonitrile-.beta.-D-glucuronic acid is produced by condensing a mandelic amide with a tri-O-acetyl methyl ester of glucuronic acid and then reacting the product with acetic anhydride to produce the tri-O-acetyl methyl ester of mandelonitrile-.beta.-D-glucuronic acid. The protecting acetyl groups may be removed and the barium salt formed by reacting with barium hydroxide, which salt, when treated with sulfuric acid, will yield the mandelonitrile-.beta.-D-glucuronic acid. This compound, as well as methacrylonitrile .beta.-D-glucuronic acid may be used in the treatment of bacterial infections having .beta.-glucuronidase activity.

Abstract: Hyperacidified tumors having high .beta.-glucuronidase activity can be treated with glucuronides with aglycones toxic to the tumor cells with great safety toward the rest of the body by first administering an alkalinizing agent in an amount sufficient to maintain the pH level of non-tumor tissues at approximately 7.4 during the glucuronide treatment. This will cause inactivation of .beta.-glucuronidase activity in the rest of the body. When nitrile-containing aglycones are used sodium thiosulfate is also administered to avoid cyanide poisoning. Novel glucuronides are disclosed the aglycones of which exert a higher toxic effect in an acid environment or are water-soluble only in an alkaline environment. Such compounds have particular utility with the above process. By substituting radioisotopes into the aglycone, diagnosis and in situ radiation therapy may be accomplished. Bacterial cells having .beta.-glucuronidase activity may also be diagnosed and treated in accordance with the present invention.